FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ralph deVere White

Research Profile

Disorders

Procedures

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Chengfei Liu; Wei Lou; Nagalakshmi Nadiminty; Xu-Bao Shi; Qinghua Zhou; Yezi Zhu; Xinbin Chen; Ralph W deVere White; Allen C Gao
Functional p53 determines docetaxel sensitivity in prostate cancer cells.
Sumaira Amir; Hsing-Jien Kung; Ai-Hong Ma; Xu-Bao Shi; Lingru Xue; Ralph W deVere White
Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer.
Benjamin A Mooso; maria mudryj; Rosalinda M Savoy; Salma Siddiqui; Sheetal Singh; Clifford G Tepper; Ruth L Vinall; Yu Wang; Roble Bedolla; Jean P Cheung; Ralph W deVere White; Hsing-Jien Kung; Anthony Martinez; Paramita M Ghosh
Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ralph deVere White (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chengfei Liu; Wei Lou; Nagalakshmi Nadiminty; Xu-Bao Shi; Qinghua Zhou; Yezi Zhu; Xinbin Chen; Ralph W deVere White; Allen C Gao
Functional p53 determines docetaxel sensitivity in prostate cancer cells.
The Prostate 2013;73(4):418-27.
2013: Sumaira Amir; Hsing-Jien Kung; Ai-Hong Ma; Xu-Bao Shi; Lingru Xue; Ralph W deVere White
Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer.
PloS one 2013;8(4):e61064.
2012: Benjamin A Mooso; maria mudryj; Rosalinda M Savoy; Salma Siddiqui; Sheetal Singh; Clifford G Tepper; Ruth L Vinall; Yu Wang; Roble Bedolla; Jean P Cheung; Ralph W deVere White; Hsing-Jien Kung; Anthony Martinez; Paramita M Ghosh
Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization.
Endocrine-related cancer 2012;19(6):759-77.
2012: Ralph W deVere White
An interview with Ralph W. deVere White. Interview by John Fitzpatrick.
BJU international 2012;110(9):1221-2.
2012: Ruth L Vinall; Jane Q Chen; Ralph W deVere White; Neil Edward Hubbard; Michael M Shen; Shola S Sulaimon; Alexander D Borowsky
Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression.
Disease models & mechanisms 2012;5(6):914-20.
2012: Ruth L Vinall; Michael S Kent; Ralph W deVere White
Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
American journal of veterinary research 2012;73(10):1626-33.
2012: Hongyong Zhang; Xiaobing Wang; Olulanu H Aina; James A Bassuk; Ralph W deVere White; Christopher P Evans; Paul Henderson; Kit S Lam; Primo Lara; Chong-Xian Pan
Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach.
Urologic oncology 2012;30(5):635-45.
2012: Christine J Jung; Candice Tahimic; Natalia Torok; Kimberly R Blahnik; Ralph W deVere White; Peggy J Farnham; Sushma Iyengar; Joy X Jiang; Mark A Zern
Human ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFβ tumor suppressor signaling pathways.
Molecular cancer research : MCR 2012;10(7):979-91.
2012: Ruth L Vinall; Sisi Wang; Chong-Xian Pan; Alexandra Z Ripoll; Ralph W deVere White
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.
International journal of cancer. Journal international du cancer 2012;130(11):2526-38.
2012: Michael C Jacobson; Ralph W deVere White; Stavros G Demos
In vivo testing of a prototype system providing simultaneous white light and near infrared autofluorescence image acquisition for detection of bladder cancer.
Journal of biomedical optics 2012;17(3):036011.
2012: Ryan K Berglund; Edith D Canby-Hagino; Peter R Carroll; E David Crawford; Ralph W deVere White; Gabriel P Haas; George P Hemstreet; Bruce A Lowe; Isaac J Powell; Catherine M Tangen; Ian M Thompson; Eric A Klein
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.
Urology 2012;79(3):633-7.
2012: Tzu-Yin Lin; Juntao Luo; Hongyong Zhang; Ralph W deVere White; Tingjuan Gao; Kit S Lam; Primo Lara; Yuanpei Li; Chong-Xian Pan
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.
International journal of nanomedicine 2012;7():2793-804.
2012: Nagalakshmi Nadiminty; Xu-Bao Shi; Ramakumar Tummala; Jin Zhang; Yezi Zhu; June X Zou; Hongwu Chen; Xinbin Chen; Ralph W deVere White; Christopher P Evans; Hsing-Jien Kung; Wei Lou; Jun Luo; Allen C Gao
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
PloS one 2012;7(3):e32832.
2011: Liqun Chen; Ralph W deVere White; Maitreyee K Jathal; Sherra D Johnson; Anisha Madhav; Margarita Mikhailova; Benjamin A Mooso; Elyse van Spyk; Ruth L Vinall; Lingru Xue; Alexandra Zierenberg-Ripoll; Paramita M Ghosh
Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(19):6218-28.
2011: Karim Chamie; John M Boone; Christopher P Evans; Theresa Koppie; Eric A Kurzrock; Primo Lara; Mark S Litwin; Sandra L Wootton-Gorges; Ralph W deVere White
Secondary malignancies among nonseminomatous germ cell tumor cancer survivors.
Cancer 2011;117(18):4219-30.
2011: Paul Henderson; Tao Li; Michael Malfatti; Laurel Beckett; Kathleen D Danenberg; Ralph W deVere White; David R Gandara; Peter P Grimminger; Miaoling He; Kenneth W Turteltaub; Hongyong Zhang; Chong-Xian Pan
A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance.
International journal of cancer. Journal international du cancer 2011;129(6):1425-34.
2011: Emil Scosyrev; V O Speights; Catherine M Tangen; E David Crawford; Ralph W deVere White; Benjamin W Ely; H Barton Grossman; Edward M Messing; Ronald B Natale; Donald L Trump; Nicholas J Vogelzang; David P Wood; Ian M Thompson
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).
BJU international 2011;108(5):693-9.
2011: Ruth L Vinall; Ryan R Davis; Regina Gandour-Edwards; Paramita M Ghosh; Zunping Luo; Christopher M Mahaffey; Clifford G Tepper; Ralph W deVere White
Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.
Hormones & cancer 2011;2(4):224-38.
2011: Laurence J Heifetz; Scott D Christensen; Ralph W deVere White; Frederick J Meyers
A model for rural oncology.
Journal of oncology practice / American Society of Clinical Oncology 2011;7(3):168-71.
2011: Baoqing Li; Xu-Bao Shi; Dattatreyudu Nori; K.S. Chao; Allen M Chen; Richard Valicenti; Ralph W deVere White
Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells.
The Prostate 2011;71(6):567-74.
2011: Xu-Bao Shi; Lingru Xue; Donghua Shi; Ralph W deVere White
Influence of short polyglutamine tracts and p160 coactivators on the transactivation of the androgen receptor.
Cancer biotherapy & radiopharmaceuticals 2011;26(2):191-201.
2011: Xu-Bao Shi; Lingru Xue; Ai-Hong Ma; Clifford G Tepper; Hsing-Jien Kung; Ralph W deVere White
miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes.
The Prostate 2011;71(5):538-49.
2011: M F Kearney; Vineet N KewalRamani; Rachel K Bagni; John M Coffin; G Q Del Prete; K A Delviks-Frankenberry; Ralph W deVere White; K Lee; Jeffrey D Lifson; W M Linehan; Frank Maldarelli; John W Mellors; Vinay Pathak; Peter A Pinto; J Spindler; Cathy D Vocke; A Wiegand; S F J Le Grice
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.
Advances in virology 2011;2011():272193.
2010: Liqun Chen; Salma Siddiqui; Swagata Bose; Benjamin Mooso; Alfredo Asuncion; Roble G Bedolla; Ruth Vinall; Clifford G Tepper; Regina Gandour-Edwards; Xubao Shi; Xiao-Hua Lu; Javed Siddiqui; Arul M Chinnaiyan; Rohit Mehra; Ralph W deVere White; Kermit L Carraway; Paramita M Ghosh
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
Cancer research 2010;70(14):5994-6003.
2010: Ralph W deVere White; Robert M Hackman; Joel Kugelmass
The dogmas of nutrition and cancer: time for a second (and maybe third) look.
Annals of the New York Academy of Sciences 2010;1190():118-25.
2010: Ralph W deVere White
Words of wisdom. Re: comparative effectiveness of minimally invasive vs open radical prostatectomy.
European urology 2010;57(2):355-6.
2010: Nicholas J Hellenthal; Michelle L Ramirez; Christopher P Evans; Ralph W deVere White
The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.
BJU international 2010;105(4):485-8.
2010: Ralph W deVere White; Alexander Tsodikov; Eschelle C Stapp; Stephanie E Soares; Hajime Fujii; Robert M Hackman
Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
Nutrition and cancer 2010;62(8):1036-43.
2009: Yair Lotan; Ashish M Kamat; Michael P Porter; Victoria L Robinson; Neal Shore; Michael Jewett; Paul F Schelhammer; Ralph W deVere White; Diane Quale; Cheryl T Lee
Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology.
Cancer 2009;115(18):4096-103.
2009: Ralph W deVere White; Primo Lara; Bryan Goldman; Cathy M Tangen; David C Smith; David P Wood Jr; Maha Hussain; E David Crawford
A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).
The Journal of urology 2009;181(6):2476-80; discussion 2480-1.
2009: Nicholas J Hellenthal; Michelle L Ramírez; Christopher P Evans; Ralph W deVere White; Theresa Koppie
Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004.
The Journal of urology 2009;181(6):2490-5.
2009: Ralph W deVere White; Ruth L Vinall; Clifford G Tepper; Xu-Bao Shi
MicroRNAs and their potential for translation in prostate cancer.
Urologic oncology 2009;27(3):307-11.
2009: Ralph W deVere White; Mark H Katz; Gary D Steinberg
The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
The Journal of urology 2009;181(5):1994-7.
2009: Nicholas J Hellenthal; Karim Chamie; Michelle L Ramirez; Ralph W deVere White
Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma.
The Journal of urology 2009;181(3):1013-8; discussion 1018-9.
2009: Roble Bedolla; Yu Wang; Alfredo Asuncion; Karim Chamie; Salma Siddiqui; maria mudryj; Thomas J Prihoda; Javed Siddiqui; Arul M Chinnaiyan; Rohit Mehra; Ralph W deVere White; Paramita M Ghosh
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):788-96.
2009: Donald A Barkauskas; Hyun Joo An; Scott R Kronewitter; Maria Lorna de Leoz; Helen K Chew; Ralph W deVere White; Gary S Leiserowitz; Suzanne Miyamoto; Carlito B Lebrilla; David Rocke
Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.
Bioinformatics (Oxford, England) 2009;25(2):251-7.
2008: Karim Chamie; Paramita M Ghosh; Theresa Koppie; V Romero; Christoph Troppmann; Ralph W deVere White
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(12):2668-73.
2008: Xu-Bao Shi; Lingru Xue; June X Zou; Regina Gandour-Edwards; Hongwu Chen; Ralph W deVere White
Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
The Prostate 2008;68(16):1816-26.
2008: Y Wang; M Mikhailova; S Bose; Chong-Xian Pan; Ralph W deVere White; Paramita M Ghosh
Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
Oncogene 2008;27(56):7106-17.
2008: Karim Chamie; Ralph W deVere White; Dennis Lee; Joon-Ha Ok; Lars M Ellison
Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
Cancer 2008;113(9):2464-70.
2008: Rebekah A Burich; William S Holland; Ruth L Vinall; Clifford G Tepper; Ralph W deVere White; Philip C Mack
Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
BJU international 2008;102(10):1458-66.
2008: Xu-Bao Shi; Clifford G Tepper; Ralph W deVere White
MicroRNAs and prostate cancer.
Journal of cellular and molecular medicine 2008;12(5A):1456-65.
2008: Michelle L Ramírez; Eric C Nelson; Ralph W deVere White; Primo Lara; Christopher P Evans
Current applications for prostate-specific antigen doubling time.
European urology 2008;54(2):291-300.
2008: Karim Chamie; Brian Hu; Ralph W deVere White; Lars M Ellison
Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?
BJU international 2008;102(3):284-90.
2008: Ralph W deVere White
Re: defining optimal therapy for muscle-invasive bladder cancer.
European urology 2008;53(6):1295-6.
2008: Xu-Bao Shi; Clifford G Tepper; Ralph W deVere White
Cancerous miRNAs and their regulation.
Cell cycle (Georgetown, Tex.) 2008;7(11):1529-38.
2008: Hong-Lin Devlin; Philip C Mack; Rebekah A Burich; Paul H Gumerlock; Hsing-Jien Kung; maria mudryj; Ralph W deVere White
Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Molecular cancer research : MCR 2008;6(5):808-18.
2008: S Liu; Ruth L Vinall; Clifford G Tepper; Xu-Bao Shi; L R Xue; Ai-Hong Ma; L-Y Wang; L D Fitzgerald; Z Wu; Regina Gandour-Edwards; Ralph W deVere White; Hsing-Jien Kung
Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
Oncogene 2008;27(4):499-505.
2008: Maria Lorna A de Leoz; Hyun Joo An; Scott Kronewitter; Jaehan Kim; Sean Beecroft; Ruth Vinall; Suzanne Miyamoto; Ralph W deVere White; Kit S Lam; Carlito B Lebrilla
Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.
Disease markers 2008;25(4-5):243-58.
2007: Xu-Bao Shi; Lingru Xue; Joy Yang; Ai-Hong Ma; Jian-Jun Zhao; Ma Xu; Clifford G Tepper; Christopher P Evans; Hsing-Jien Kung; Ralph W deVere White
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(50):19983-8.
2007: Sang Soo Hah; Rhoda A Sumbad; Ralph W deVere White; Kenneth W Turteltaub; Paul Henderson
Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations.
Chemical research in toxicology 2007;20(12):1745-51.
2007: Ruth L Vinall; Kimberley Hwa; Paramita M Ghosh; Chong-Xian Pan; Primo Lara; Ralph W deVere White
Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6204-16.
2007: Yu Wang; Jeffrey I Kreisberg; Roble Bedolla; Margarita Mikhailova; Ralph W deVere White; Paramita M Ghosh
A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.
Oncogene 2007;26(41):6061-70.
2007: maria mudryj; Elizabeth Reay; Laurel Beckett; Satya Dandekar; Ralph W deVere White; Regina Gandour-Edwards
Novel p53/p130 axis in bladder tumors.
Urology 2007;70(3):608-12.
2007: Ralph W deVere White
Finasteride for chemoprevention of prostate cancer: why has it not been embraced?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):2999-3000.
2007: Angelo J Cambio; Lars M Ellison; Karim Chamie; Ralph W deVere White; Christopher P Evans
Cost-benefit and outcome analysis: effect of prostate biopsy undergrading.
Urology 2007;69(6):1152-6.
2007: Xu-Bao Shi; Lingru Xue; Clifford G Tepper; Regina Gandour-Edwards; Paramita M Ghosh; Hsing-Jien Kung; Ralph W deVere White
The oncogenic potential of a prostate cancer-derived androgen receptor mutant.
The Prostate 2007;67(6):591-602.
2007: Clifford G Tepper; Ruth L Vinall; Christopher B Wee; Lingru Xue; Xu-Bao Shi; Rebekah Burich; Philip C Mack; Ralph W deVere White
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
The Prostate 2007;67(5):521-35.
2007: E C Nelson; Christopher P Evans; Philip C Mack; Ralph W deVere White; Primo Lara
Inhibition of Akt pathways in the treatment of prostate cancer.
Prostate cancer and prostatic diseases 2007;10(4):331-9.
2007: Yi-Chun Liao; Lizhen Si; Ralph W deVere White; Su Hao Lo
The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
The Journal of cell biology 2007;176(1):43-9.
2006: H Barton Grossman; Catherine M Tangen; Carlos Cordon-Cardo; Richard J Cote; Frederic M Waldman; Ralph W deVere White; Anand Karnad; Michael Glode; E David Crawford
Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study.
Oncology reports 2006;16(4):807-10.
2006: June X Zou; Zhenyu Zhong; Xu-Bao Shi; Clifford G Tepper; Ralph W deVere White; Hsing-Jien Kung; Hongwu Chen
ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
The Prostate 2006;66(14):1474-86.
2006: Alexander D Borowsky; Karen H Dingley; Esther A Ubick; Kenneth W Turteltaub; Robert Cardiff; Ralph W deVere White
Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model.
Neoplasia (New York, N.Y.) 2006;8(9):708-15.
2006: Primo Lara; Ralph W deVere White
Accrual issues in genitourinary cancer clinical trials.
Urologic oncology 2006;24(5):379-83.
2006: Ai-Hong Ma; Liang Xia; Sonal J Desai; David Boucher; Yi Guan; Hsiu-Ming Shih; Xu-Bao Shi; Ralph W deVere White; Hongwu Chen; Clifford G Tepper; Hsing-Jien Kung
Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.
Cancer research 2006;66(17):8439-47.
2006: Patricia A Burke; Jeffrey P Gregg; Brandon Bakhtiar; Laurel Beckett; Gerald L DeNardo; Huguette Albrecht; Ralph W deVere White; Sally J De Nardo
Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules.
International journal of oncology 2006;29(1):49-55.
2006: Sang Soo Hah; Kristen M Stivers; Ralph W deVere White; Paul Henderson
Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry.
Chemical research in toxicology 2006;19(5):622-6.
2006: Ralph W deVere White
Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits?
Nature clinical practice. Urology 2006;3(5):254-5.
2006: Ruth L Vinall; Clifford G Tepper; Xu-Bao Shi; L A Xue; Regina Gandour-Edwards; Ralph W deVere White
The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7.
Oncogene 2006;25(14):2082-93.
2006: Zongbing You; Xu-Bao Shi; Grayson DuRaine; Dominik R Haudenschild; Clifford G Tepper; Su Hao Lo; Regina Gandour-Edwards; Ralph W deVere White; Hari Reddi
Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
Cancer research 2006;66(1):175-83.
2005: Clifford G Tepper; Jeffrey P Gregg; Xu-Bao Shi; Ruth L Vinall; Colin A Baron; Philip E Ryan; Pierre-Yves Desprez; Hsing-Jien Kung; Ralph W deVere White
Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
The Prostate 2005;65(4):375-89.
2005: Javid Javidan; Arline D Deitch; Xu-Bao Shi; Ralph W deVere White
The androgen receptor and mechanisms for androgen independence in prostate cancer.
Cancer investigation 2005;23(6):520-8.
2005: Yelena B Wetherill; Nicola L Fisher; Ann Staubach; Mark Danielsen; Ralph W deVere White; Karen E Knudsen
Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.
Cancer research 2005;65(1):54-65.
2004: Xu-Bao Shi; Regina Gandour-Edwards; Laurel Beckett; Arline D Deitch; Ralph W deVere White
A modified yeast assay used on archival samples of localized prostate cancer tissue improves the detection of p53 abnormalities and increases their predictive value.
BJU international 2004;94(7):996-1002.
2004: Edward Karpman; Zelanna Goldberg; Amir Saffarian; Regina Gandour-Edwards; Lars M Ellison; Ralph W deVere White
Analysis of treatment for small cell cancer of the bladder and report of three cases.
Urology 2004;64(3):494-8.
2004: Xu-Bao Shi; Ai-Hong Ma; Clifford G Tepper; Liang Xia; Jeffrey P Gregg; Regina Gandour-Edwards; Philip C Mack; Hsing-Jien Kung; Ralph W deVere White
Molecular alterations associated with LNCaP cell progression to androgen independence.
The Prostate 2004;60(3):257-71.
2004: Harry W Herr; James R Faulkner; H Barton Grossman; Ronald B Natale; Ralph W deVere White; Michael F Sarosdy; E David Crawford
Surgical factors influence bladder cancer outcomes: a cooperative group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2781-9.
2004: Stavros G Demos; Regina Gandour-Edwards; Rajendra Ramsamooj; Ralph W deVere White
Spectroscopic detection of bladder cancer using near-infrared imaging techniques.
Journal of biomedical optics 2004;9(4):767-71.
2004: Stavros G Demos; Regina Gandour-Edwards; Rajendra Ramsamooj; Ralph W deVere White
Near-infrared autofluorescence imaging for detection of cancer.
Journal of biomedical optics 2004;9(3):587-92.
2004: Bruce R Madewell; Regina Gandour-Edwards; Ralph W deVere White
Canine prostatic intraepithelial neoplasia: is the comparative model relevant?
The Prostate 2004;58(3):314-7.
2004: Ralph W deVere White; Robert M Hackman; Stephanie E Soares; Laurel Beckett; Yueju Li; Buxiang Sun
Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
Urology 2004;63(2):259-63.
2004: Regina Gandour-Edwards; Philip C Mack; Ralph W deVere White; Paul H Gumerlock
Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia.
Prostate cancer and prostatic diseases 2004;7(4):321-6.
2004: X Wu; T Obata; Q Khan; R A Highshaw; Ralph W deVere White; Colleen Sweeney
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
BJU international 2004;93(1):143-50.
2003: H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood Jr; Derek Raghavan; E David Crawford
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
The New England journal of medicine 2003;349(9):859-66.
2003: Ralph A Highshaw; Stacy T Tanaka; Christopher P Evans; Ralph W deVere White
Is bladder biopsy necessary at three or six months post BCG therapy?
Urologic oncology 2003;21(3):207-9.
2003: Nancy J Nesslinger; Xu-Bao Shi; Ralph W deVere White
Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.
Cancer research 2003;63(9):2228-33.
2002: Xu-Bao Shi; Stephen M Di Mauro; Ralph A Highshaw; Arline D Deitch; Christopher P Evans; Paul H Gumerlock; Ralph W deVere White
Application of a yeast assay to detect functional p53 mutations in archival prostate cancer tissue.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):657-64.
2002: Susan L Scott; Roger Higdon; Laurel Beckett; Xu-Bao Shi; Ralph W deVere White; John D Earle; Paul H Gumerlock
BCL2 antisense reduces prostate cancer cell survival following irradiation.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):647-56.
2002: Isaac J Powell; Catherine M Tangen; Gary J Miller; Bruce A Lowe; Gabriel P Haas; Peter R Carroll; Michael B Osswald; Ralph W deVere White; Ian M Thompson; E David Crawford
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.
The Journal of urology 2002;168(5):2016-9.
2002: Ralph W deVere White; Robert M Hackman; Stephanie E Soares; Laurel Beckett; Buxiang Sun
Effects of a mushroom mycelium extract on the treatment of prostate cancer.
Urology 2002;60(4):640-4.
2002: Regina Gandour-Edwards; Primo Lara; Ann K Folkins; Janine M LaSalle; Laurel Beckett; Yueju Li; Frederick J Meyers; Ralph W deVere White
Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
Cancer 2002;95(5):1009-15.
2002: Xu-Bao Shi; Nancy J Nesslinger; Arline D Deitch; Paul H Gumerlock; Ralph W deVere White
Complex functions of mutant p53 alleles from human prostate cancer.
The Prostate 2002;51(1):59-72.
2002: Xu-Bao Shi; Ai-Hong Ma; Liang Xia; Hsing-Jien Kung; Ralph W deVere White
Functional analysis of 44 mutant androgen receptors from human prostate cancer.
Cancer research 2002;62(5):1496-502.
2002: Jonathan A Eandi; Ralph W deVere White; H S G R Tunuguntla; C H Bohringer; Christopher P Evans
Can single dose preoperative intrathecal morphine sulfate provide cost-effective postoperative analgesia and patient satisfaction during radical prostatectomy in the current era of cost containment?
Prostate cancer and prostatic diseases 2002;5(3):226-30.
2001: Xu-Bao Shi; Paul H Gumerlock; JT Muenzer; Ralph W deVere White
BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents.
Cancer biotherapy & radiopharmaceuticals 2001;16(5):421-9.
2001: H L Liu; Regina Gandour-Edwards; Primo Lara; Ralph W deVere White; Janine M LaSalle
Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
Cancer journal (Sudbury, Mass.) 2001;7(5):395-403.
2001: S G Williams; Regina Gandour-Edwards; Arline D Deitch; S Toscano; J J Fan; Cora N Sternberg; Vito Pansadoro; Fabio Calabrò; A Rossetti; Ralph W deVere White
Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patients.
European urology 2001;39(4):430-7.
2000: Richard B Wilder; R H Chou; J K Ryu; R L Stern; Michael S Wong; M Ji; M Roach; Ralph W deVere White
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
American journal of clinical oncology 2000;23(4):330-3.
2000: W H Hall; John P McGahan; DP Link; Ralph W deVere White
Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor.
AJR. American journal of roentgenology 2000;174(6):1592-4.
2000: J K Dow; Ralph W deVere White
Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions.
Urology 2000;55(6):800-6.
2000: Ralph W deVere White; Arline D Deitch; Siamak Daneshmand; Brent Blumenstein; Bruce A Lowe; A I Sagalowsky; J A Smith; Paul F Schellhammer; T H Stanisic; H Barton Grossman; E Messing; JD Crissman; E D Crawford
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group Study.
European urology 2000;37(5):595-600.
2000: Ralph W deVere White
Present and future management of prostate cancer.
Cancer biotherapy & radiopharmaceuticals 2000;15(2):121-5.
2000: Richard B Wilder; J Y Hsiang; M Ji; John D Earle; Ralph W deVere White
Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy.
American journal of clinical oncology 2000;23(2):176-80.
2000: R H Chou; Richard B Wilder; M Ji; Janice K Ryu; BR Leigh; John D Earle; R L Doggett; HD Kubo; Mack Roach; Ralph W deVere White
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy.
International journal of radiation oncology, biology, physics 2000;47(1):115-9.
2000: Martin J Edelman; Frederick J Meyers; T R Miller; S G Williams; Regina Gandour-Edwards; Ralph W deVere White
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation.
Urology 2000;55(4):521-5.
1999: Claus G Roehrborn; Peter Boyle; D Bergner; T Gray; Marc Gittelman; T Shown; Arnold Melman; R B Bracken; Ralph W deVere White; A Taylor; D Wang; Joanne Waldstreicher
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.
Urology 1999;54(4):662-9.
1999: Ralph W deVere White; Arline D Deitch; Paul H Gumerlock; Xu-Bao Shi
Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions.
The Prostate 1999;41(2):134-42.
1999: Nicholas J Hegarty; John M Fitzpatrick; J P Richie; Peter T Scardino; Ralph W deVere White; F H Schröder; Donald S Coffey
Future prospects in prostate cancer.
The Prostate 1999;40(4):261-8.
1999: L M Gumbiner; Paul H Gumerlock; Philip C Mack; SG Chi; Ralph W deVere White; J L Mohler; T G Pretlow; JV Tricoli
Overexpression of cyclin D1 is rare in human prostate carcinoma.
The Prostate 1999;38(1):40-5.
1998: Frederick J Meyers; Paul H Gumerlock; SG Chi; H Borchers; Arline D Deitch; Ralph W deVere White
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.
Cancer 1998;83(12):2534-9.
1998: Ralph W deVere White; E Stapp
Predicting prognosis in patients with superficial bladder cancer.
Oncology (Williston Park, N.Y.) 1998;12(12):1717-23; discussion 1724-6.
1998: Frederick J Meyers; Ralph W deVere White
Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
The Western journal of medicine 1998;168(6):525.
1998: Ralph W deVere White; Arline D Deitch; A G Jackson; Regina Gandour-Edwards; J Marshalleck; S E Soares; S N Toscano; Jennine M Lunetta; S L Stewart
Racial differences in clinically localized prostate cancers of black and white men.
The Journal of urology 1998;159(6):1979-82; discussion 1982-3.
1998: Philip C Mack; SG Chi; Frederick J Meyers; S L Stewart; Ralph W deVere White; Paul H Gumerlock
Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade.
The Prostate 1998;34(2):145-51.
1997: SG Chi; Ralph W deVere White; JT Muenzer; Paul H Gumerlock
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(10):1889-97.
1997: Michael F Sarosdy; M A Hudson; William J Ellis; Mark S Soloway; Ralph W deVere White; Joel Sheinfeld; M V Jarowenko; Paul F Schellhammer; E W Schervish; J V Patel; Gerald Chodak; D L Lamm; R D Johnson; M Henderson; Greg Adams; Brent Blumenstein; Kent Thoelke; R D Pfalzgraf; H A Murchison; S L Brunelle
Improved detection of recurrent bladder cancer using the Bard BTA stat Test.
Urology 1997;50(3):349-53.
1997: Richard B Wilder; P D Fone; D E Rademacher; C D Jones; Mack Roach; John D Earle; Ralph W deVere White
Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy.
International journal of radiation oncology, biology, physics 1997;38(4):737-41.
1997: Jiann-an Tan; Y Sharief; Katherine G Hamil; Christopher W Gregory; D Y Zang; M Sar; Paul H Gumerlock; Ralph W deVere White; T G Pretlow; Stephen E Harris; Elizabeth M Wilson; James L Mohler; Frank S French
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
Molecular endocrinology (Baltimore, Md.) 1997;11(4):450-9.
1997: Ralph W deVere White; Frederick J Meyers; SG Chi; S Chamberlain; D Siders; F Lee; S Stewart; Paul H Gumerlock
Human androgen receptor expression in prostate cancer following androgen ablation.
European urology 1997;31(1):1-6.
1997: Paul H Gumerlock; SG Chi; Xu-Bao Shi; H James Voeller; J W Jacobson; Edward P Gelmann; Ralph W deVere White
p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Journal of the National Cancer Institute 1997;89(1):66-71.
1996: Xu-Bao Shi; S M Bodner; Ralph W deVere White; Paul H Gumerlock
Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1996;5(4):271-8.
1996: S E Litwiller; K B Kim; P D Fone; Ralph W deVere White; Anthony R Stone
Post-prostatectomy incontinence and the artificial urinary sphincter: a long-term study of patient satisfaction and criteria for success.
The Journal of urology 1996;156(6):1975-80.
1996: M Nagabhushan; C M Miller; Theresa P Pretlow; J M Giaconia; N L Edgehouse; Stuart Schwartz; Hsing-Jien Kung; Ralph W deVere White; Paul H Gumerlock; Martin I Resnick; Saeid B Amini; Thomas G Pretlow
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.
Cancer research 1996;56(13):3042-6.
1996: I E Wertz; Arline D Deitch; Paul H Gumerlock; Regina Gandour-Edwards; S G Chi; Ralph W deVere White
Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues.
Human pathology 1996;27(6):573-80.
1996: H Borchers; Frederick J Meyers; Paul H Gumerlock; S L Stewart; Ralph W deVere White
NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
The Journal of urology 1996;155(6):2080-4.
1996: S H Glick; Lydia Pleotis Howell; Ralph W deVere White
Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder.
The Journal of urology 1996;155(5):1754-7.
1996: JV Tricoli; Paul H Gumerlock; J L Yao; SG Chi; S A D'Souza; B R Nestok; Ralph W deVere White
Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
Genes, chromosomes & cancer 1996;15(2):108-14.
1996: Ralph W deVere White; A D Deitch; H Tesluk; B Blumensteinj; B A Lowe; A I Sagalowsky; J A Smith; Paul F Schellhammer; T H Stanisic; H Barton Grossman; E Messing; JD Crissman; E D Crawford
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study.
Urologic oncology 1996;2(1):27-34.
1996: Xu-Bao Shi; Paul H Gumerlock; Ralph W deVere White
Molecular biology of prostate cancer.
World journal of urology 1996;14(5):318-28.
1995: Sally J DeNardo; Paul H Gumerlock; Michelle D Winthrop; Philip C Mack; S G Chi; Kathleen R Lamborn; Sui Shen; Laird A Miers; Ralph W deVere White; Gerald L DeNardo
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
Cancer research 1995;55(23 Suppl):5837s-5841s.
1995: Michael F Sarosdy; Ralph W deVere White; Mark S Soloway; Joel Sheinfeld; M A Hudson; P F Schellhammer; M V Jarowenko; Greg Adams; B A Blumenstein
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.
The Journal of urology 1995;154(2 Pt 1):379-83; discussion 383-4.
1995: A Huang; R K Low; Ralph W deVere White
Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma.
The Journal of urology 1995;153(3 Pt 2):1041-2.
1994: J R Fishman; Paul H Gumerlock; Frederick J Meyers; Ralph W deVere White
Quantitation of NM23 expression in human prostate tissues.
The Journal of urology 1994;152(1):202-7.
1994: SG Chi; Ralph W deVere White; Frederick J Meyers; D B Siders; F Lee; Paul H Gumerlock
p53 in prostate cancer: frequent expressed transition mutations.
Journal of the National Cancer Institute 1994;86(12):926-33.
1994: F Schröder; B Tribukait; Alfred Böcking; Ralph W deVere White; L Koss; M Lieber; B Stenkvist; A Zetterberg
Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Scandinavian journal of urology and nephrology. Supplementum 1994;162():51-63; discussion 15-27.
1993: Frederick J Meyers; SG Chi; J R Fishman; Ralph W deVere White; Paul H Gumerlock
p53 mutations in benign prostatic hyperplasia.
Journal of the National Cancer Institute 1993;85(22):1856-8.
1993: Arline D Deitch; Ralph W deVere White; Bruce R Madewell
False DNA aneuploidy in canine and human neoplasms.
Anticancer research 1993;13(6A):2117-8.
1993: Arline D Deitch; G J Miller; Ralph W deVere White
Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
Cancer 1993;72(5):1692-700.
1993: John P McGahan; L C Blake; Ralph W deVere White; Eugenio O Gerscovich; W E Brant
Color flow sonographic mapping of intravascular extension of malignant renal tumors.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1993;12(7):403-9.
1993: D R Couillard; Ralph W deVere White
Surgery of renal cell carcinoma.
The Urologic clinics of North America 1993;20(2):263-75.
1993: Lydia Pleotis Howell; Arline D Deitch; V A Andreotti; L A Westrick; Ralph W deVere White
Fixation method useful for cytologic examination and DNA flow cytometry of exfoliated bladder cells.
Urology 1993;41(5):472-5.
1993: J R Fishman; D T Walton; N M Flynn; Daniel R Benson; Ralph W deVere White
Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy.
The Journal of urology 1993;149(3):584-7.
1993: Leon L Wheeless; R A Badalament; Ralph W deVere White; Y Fradet; B Tribukait
Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.
Cytometry 1993;14(5):478-81.
1992: Arline D Deitch; Ralph W deVere White
Flow cytometry as a predictive modality in prostate cancer.
Human pathology 1992;23(4):352-9.
1992: Ralph W deVere White; Frederick J Meyers; S E Soares; D G Miller; T F Soriano
Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy.
The Journal of urology 1992;147(3 Pt 2):947-51.
1992: G A Broderick; John P McGahan; Anthony R Stone; Ralph W deVere White
The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound.
The Journal of urology 1992;147(1):57-61.
1992: Ralph W deVere White; Arline D Deitch
Evaluation of DNA flow cytometry as a screening test for bladder cancer.
Journal of cellular biochemistry. Supplement 1992;16I():80-4.
1991: Frederick J Meyers; Paul H Gumerlock; E S Kawasaki; A M Wang; Ralph W deVere White; Henry A Erlich
Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction.
Cancer 1991;67(8):2087-95.
1991: Paul H Gumerlock; U R Poonamallee; Frederick J Meyers; Ralph W deVere White
Activated ras alleles in human carcinoma of the prostate are rare.
Cancer research 1991;51(6):1632-7.
1991: Leon L Wheeless; John S Coon; Christopher Cox; Arline D Deitch; Ralph W deVere White; Y Fradet; L G Koss; M R Melamed; Mary J O'Connell; Jay E Reeder
Precision of DNA flow cytometry in inter-institutional analyses.
Cytometry 1991;12(5):405-12.
1991: B R Madewell; Arline D Deitch; R J Higgins; Stanley L Marks; Ralph W deVere White
DNA flow cytometric study of the hyperplastic and neoplastic canine prostate.
The Prostate 1991;18(2):173-9.
1990: G A Broderick; Anthony R Stone; Ralph W deVere White
Neobladders: clinical management and considerations for patients receiving chemotherapy.
Seminars in oncology 1990;17(5):598-605.
1990: Arline D Deitch; K A Anderson; Ralph W deVere White
Evaluation of DNA flow cytometry as a screening test for bladder cancer.
Journal of occupational medicine. : official publication of the Industrial Medical Association 1990;32(9):898-903.
1990: Ralph W deVere White
Neoadjuvant therapy of carcinoma of the bladder.
Seminars in urology 1990;8(3):197-200.
1990: Wayne J G Hellstrom; H Tesluk; Arline D Deitch; Ralph W deVere White
Comparison of flow cytometry to routine testicular biopsy in male infertility.
Urology 1990;35(4):321-6.
1990: Arline D Deitch; V A Andreotti; M A Strand; Lydia Pleotis Howell; Ralph W deVere White
A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients.
The Journal of urology 1990;143(4):700-5.
1990: Lydia Pleotis Howell; T R Amott; Ralph W deVere White
Aspiration biopsy cytology of the prostate in young adult men.
Diagnostic cytopathology 1990;6(2):89-94.
1989: Frederick J Meyers; Paul H Gumerlock; R L Teplitz; S L Hatcher; Ralph W deVere White
Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells.
The Journal of urology 1989;142(6):1599-601.
1989: Leon L Wheeless; John S Coon; Christopher Cox; Arline D Deitch; Ralph W deVere White; L G Koss; M R Melamed; Mary J O'Connell; Jay E Reeder; R S Weinstein
Measurement variability in DNA flow cytometry of replicate samples.
Cytometry 1989;10(6):731-8.
1989: M D Wolach; J P MacDermott; Anthony R Stone; Ralph W deVere White
Treatment and complications of Fournier's gangrene.
British journal of urology 1989;64(3):310-4.
1989: Arline D Deitch; M A Strand; Ralph W deVere White
Deoxyribonucleic acid flow cytometry of benign prostatic disease.
The Journal of urology 1989;142(3):759-62.
1989: Wayne J G Hellstrom; Anthony R Stone; Arline D Deitch; Ralph W deVere White
The clinical application of aspiration deoxyribonucleic acid flow cytometry to neurologically impaired men entering an electroejaculation program.
The Journal of urology 1989;142(2 Pt 1):309-12.
1989: Paul H Gumerlock; Frederick J Meyers; S P Kokoris; G Wong; F P McCormick; Ralph W deVere White
RAS enzyme-linked immunoblot assay discriminates p21 species: a technique to dissect gene family expression.
Analytical biochemistry 1989;180(1):158-68.
1989: Frederick J Meyers; Paul H Gumerlock; S P Kokoris; Ralph W deVere White; F McCormick
Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants.
Cancer 1989;63(11):2177-81.
1989: D K Hermansen; M R Melamed; John S Coon; R S Weinstein; Ralph W deVere White; Arline D Deitch; Leon L Wheeless; Jay E Reeder; R Wersto; L G Koss
Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network.
Cancer 1989;63(9):1780-3.
1989: John S Coon; Arline D Deitch; Ralph W deVere White; L G Koss; M R Melamed; Jay E Reeder; R S Weinstein; R P Wersto; Leon L Wheeless
Check samples for laboratory self-assessment in DNA flow cytometry. The National Cancer Institute's Flow Cytometry Network experience.
Cancer 1989;63(8):1592-9.
1989: Wayne J G Hellstrom; Arline D Deitch; Ralph W deVere White
Evaluation of vasovasostomy candidates by deoxyribonucleic acid flow cytometry of testicular aspirates.
Fertility and sterility 1989;51(3):546-8.
1989: Paul H Gumerlock; Frederick J Meyers; B A Foster; T G Kawakami; Ralph W deVere White
Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid.
Radiation research 1989;117(2):198-206.
1989: Frederick J Meyers; S J Denardo; D Macey; Ralph W deVere White; M Unger
Development of monoclonal antibody imaging of metastatic prostatic carcinoma.
The Prostate 1989;14(3):209-20.
1988: Leon L Wheeless; John S Coon; Arline D Deitch; Ralph W deVere White; L G Koss; M R Melamed; Jay E Reeder; R D Robinson; R S Weinstein; R P Wersto
Comparison of automated and manual techniques for analysis of DNA frequency distributions in bladder washings.
Cytometry 1988;9(6):600-4.
1988: W C Baker; Ralph W deVere White; PV Rossitto; B H Min; Robert Cardiff
Quantitative analysis of keratin 18 in the urine of patients with bladder cancer.
The Journal of urology 1988;140(2):436-9.
1988: PV Rossitto; R Chan; M A Strand; C H Miller; W C Baker; Arline D Deitch; Ralph W deVere White; Robert Cardiff
Characterization of urinary keratin number 18 using a new assay.
The Journal of urology 1988;140(2):431-5.
1988: Ralph W deVere White; Arline D Deitch; W C Baker; M A Strand
Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer.
The Journal of urology 1988;139(5):926-8.
1988: I S Sawczuk; C A Olsson; Ralph W deVere White
The limited usefulness of external beam radiotherapy in the control of superficial bladder cancer.
British journal of urology 1988;61(4):330-2.
1988: W C Baker; L B Goldman; Ralph W deVere White
Pseudomyxoma peritonei presenting as a scrotal mass.
The Journal of urology 1988;139(4):821-2.
1988: W C Baker; Frederick J Meyers; Ralph W deVere White
Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer.
Journal of surgical oncology 1988;37(3):165-7.
1988: Ralph W deVere White; Arline D Deitch; B West; J M Fitzpatrick
The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer.
The Journal of urology 1988;139(2):279-82.
1988: W C Baker; M B Bishai; Ralph W deVere White
Misleading testicular masses.
Urology 1988;31(2):111-3.
1988: John S Coon; Arline D Deitch; Ralph W deVere White; L G Koss; M R Melamed; Jay E Reeder; R S Weinstein; R P Wersto; Leon L Wheeless
Interinstitutional variability in DNA flow cytometric analysis of tumors. The National Cancer Institute's Flow Cytometry Network Experience.
Cancer 1988;61(1):126-30.
1987: W C Baker; M A Russo; Ralph W deVere White
Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
Urology 1987;30(4):357-8.
1987: R H Sherman; L B Goldman; Ralph W deVere White
Filarial chyluria as a cause of acute urinary retention.
Urology 1987;29(6):642-5.
1986: Ralph W deVere White; C A Olsson; Arline D Deitch
Flow cytometry: role in monitoring transitional cell carcinoma of bladder.
Urology 1986;28(1):15-20.
1985: Harris M Nagler; X Z Li; E F Lizza; Arline D Deitch; Ralph W deVere White
Varicocele: temporal considerations.
The Journal of urology 1985;134(2):411-3.
1985: Ralph W deVere White; Arline D Deitch
The role of flow cytometry in urologic disease.
Seminars in urology 1985;3(2):132-45.
1985: I Sawczuk; M Tannenbaum; C A Olsson; Ralph W deVere White
Primary transitional cell carcinoma of prostatic periurethral ducts.
Urology 1985;25(4):339-43.
1985: Ralph W deVere White; Arline D Deitch; W K Hong; C A Olsson
The influence of cytoreductive surgery on the response to chemotherapy of a rat renal cancer.
Urological research 1985;13(1):35-8.
1984: Ralph W deVere White
Nonsurgical management of patients with stage D1 adenocarcinoma of prostate: risks vs benefits.
Urology 1984;24(5 Suppl):12-5.
1984: S D Goldberg; Arline D Deitch; M Schevchuck; Harris M Nagler; Ralph W deVere White
Comparison of histologic and flow cytometric evaluation of cyclophosphamide-induced testicular damage.
Urology 1984;24(5):472-5.
1984: Harris M Nagler; Arline D Deitch; Ralph W deVere White
Testicular torsion: temporal considerations.
Fertility and sterility 1984;42(2):257-62.
1984: Ralph Buttyan; P Tomashefsky; Arline D Deitch; Carl A Olsson; Ralph W deVere White
Alterations of physical and biochemical parameters of the R3327-CP rat prostate adenocarcinoma following hormonal manipulation of the host.
The Journal of urology 1984;131(6):1218-24.
1984: R J Krane; Ralph W deVere White; Z Davis; R Sterling; D B Dobnik; J R McCormick
Removal of renal cell carcinoma extending into the right atrium using cardiopulmonary bypass, profound hypothermia and circulatory arrest.
The Journal of urology 1984;131(5):945-7.
1984: Harris M Nagler; Ralph W deVere White; M Roberts
Familial idiopathic priapism: a case report.
The Journal of urology 1984;131(3):542-3.
1984: Ralph W deVere White
The impact of lymphnode metastases in renal adenocarcinoma: prognostic impact and effect of lymphadenectomy.
Progress in clinical and biological research 1984;153():437-9.
1983: Harris M Nagler; Ralph W deVere White; I Dyrenfurth; W C Hembree
The effect of delta 1-testolactone on serum testosterone and estradiol in the adult male rat.
Fertility and sterility 1983;40(6):818-22.
1983: Ralph W deVere White
Radiation and chemotherapy for stage D1 prostate cancer.
Seminars in urology 1983;1(4):261-8.
1983: Ralph W deVere White; R K Babayan; J Krikorian; R J Krane; C A Olsson
Adjuvant chemotherapy for stage D1 adenocarcinoma of prostate.
Urology 1983;21(3):270-2.
1983: Ralph W deVere White; M O'Brien; J Krikorian; R Babayan; C A Olsson
Maytansine as a cause of acute proliferative disorder of bladder urothelium in the rat.
Cancer treatment reports 1983;67(2):183-4.
1983: Ralph W deVere White; Arline D Deitch; C A Olsson
Limitations of DNA histogram analysis by flow cytometry as a method of predicting chemosensitivity in a rat renal cancer model.
Cancer research 1983;43(2):604-10.
1983: I S Sawczuk; Ralph W deVere White; R P Gold; C A Olsson
Sensitivity of computed tomography in evaluation of pelvic lymph node metastases from carcinoma of bladder and prostate.
Urology 1983;21(1):81-4.
1983: W G Walsh; P Tomashefsky; Carl A Olsson; Ralph W deVere White
Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.
Urological research 1983;11(6):263-5.
1982: Harris M Nagler; Ralph W deVere White
The effect of testicular torsion on the contralateral testis.
The Journal of urology 1982;128(6):1343-8.
1982: Arline D Deitch; H Law; Ralph W deVere White
A stable propidium iodide staining procedure for flow cytometry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1982;30(9):967-72.
1982: Ralph W deVere White; R K Babaian; M Feldman; R J Krane; C A Olsson
Adjunctive therapy with interstitial irradiation for prostate cancer.
Urology 1982;19(4):395-8.
1982: Ralph W deVere White; W Ki Hong; M Tannenbaum; C A Olsson
Chemosensitivity of murine renal carcinoma.
Urological research 1982;10(1):27-30.
1981: Ralph W deVere White; S Karian; W K Hong; C A Olsson
Testis tumor markers: how accurate are they?
The Journal of urology 1981;125(5):661-3.
1979: C A Olsson; Ralph W deVere White; I Goldstein; A M Traish; R E Müller; H H Wotiz
A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
Progress in clinical and biological research 1979;33():209-21.
1977: D F Paulson; C B Hammond; Ralph W deVere White; R H Wiebe
Clomiphene citrate: pharmacologic treatment of hypofertile male.
Urology 1977;9(4):419-21.
1977: Ralph W deVere White; D F Paulson; J F Glenn
The clinical spectrum of prostate cancer.
The Journal of urology 1977;117(3):323-7.